Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Moreira

Showing results (71-80 of 142) with videos related to

Pageof 15
Sort By:
The Prostate|March 13, 2026
Does Insulin Resistance Predict Lower Urinary Tract Symptoms? Results From the Reduction by Dutasteride of Prostate Cancer (REDUCE) TrialRenning Zheng, James P Daniels, James M Mirocha, et al.
Journal of Endourology|November 14, 2014
Continuing aspirin therapy during percutaneous nephrolithotomy: unsafe or under-utilized?David A Leavitt, Nithin Theckumparampil, Daniel M Moreira, et al.
Urology|December 3, 2014
Percutaneous nephrolithotomy during uninterrupted aspirin therapy in high-cardiovascular risk patients: preliminary reportDavid A Leavitt, Nithin Theckumparampil, Daniel M Moreira, et al.
BJU International|November 17, 2009
Definition and preoperative predictors of persistently elevated prostate-specific antigen after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) databaseDaniel M Moreira, Joseph C Presti, William J Aronson, et al.
BJU International|June 17, 2014
Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) studyKatharine N Sourbeer, Lauren E Howard, Gerald L Andriole, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 11, 2017
Statin Use, Serum Lipids, and Prostate Inflammation in Men with a Negative Prostate Biopsy: Results from the REDUCE TrialEmma H Allott, Lauren E Howard, Adriana C Vidal, et al.
The Journal of Urology|September 18, 2009
Natural history of persistently elevated prostate specific antigen after radical prostatectomy: results from the SEARCH databaseDaniel M Moreira, Joseph C Presti, William J Aronson, et al.
European Urology|April 2, 2013
Obesity is associated with increased prostate growth and attenuated prostate volume reduction by dutasterideRoberto L Muller, Leah Gerber, Daniel M Moreira, et al.
The Journal of Urology|July 14, 2015
Baseline Prostate Atrophy is Associated with Reduced Risk of Prostate Cancer in Men Undergoing Repeat Prostate BiopsyDaniel M Moreira, David G Bostwick, Gerald L Andriole, et al.
BJU International|September 24, 2013
The surgical spectacle: a survey of urologists viewing live case demonstrationsSammy E Elsamra, Mathew Fakhoury, Hector Motato, et al.
Pageof 15

Showing results (71-80 of 142) with videos related to

Sort By:
Pageof 15
The Prostate|March 13, 2026
Does Insulin Resistance Predict Lower Urinary Tract Symptoms? Results From the Reduction by Dutasteride of Prostate Cancer (REDUCE) TrialRenning Zheng, James P Daniels, James M Mirocha, et al.
Journal of Endourology|November 14, 2014
Continuing aspirin therapy during percutaneous nephrolithotomy: unsafe or under-utilized?David A Leavitt, Nithin Theckumparampil, Daniel M Moreira, et al.
Urology|December 3, 2014
Percutaneous nephrolithotomy during uninterrupted aspirin therapy in high-cardiovascular risk patients: preliminary reportDavid A Leavitt, Nithin Theckumparampil, Daniel M Moreira, et al.
BJU International|November 17, 2009
Definition and preoperative predictors of persistently elevated prostate-specific antigen after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) databaseDaniel M Moreira, Joseph C Presti, William J Aronson, et al.
BJU International|June 17, 2014
Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) studyKatharine N Sourbeer, Lauren E Howard, Gerald L Andriole, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 11, 2017
Statin Use, Serum Lipids, and Prostate Inflammation in Men with a Negative Prostate Biopsy: Results from the REDUCE TrialEmma H Allott, Lauren E Howard, Adriana C Vidal, et al.
The Journal of Urology|September 18, 2009
Natural history of persistently elevated prostate specific antigen after radical prostatectomy: results from the SEARCH databaseDaniel M Moreira, Joseph C Presti, William J Aronson, et al.
European Urology|April 2, 2013
Obesity is associated with increased prostate growth and attenuated prostate volume reduction by dutasterideRoberto L Muller, Leah Gerber, Daniel M Moreira, et al.
The Journal of Urology|July 14, 2015
Baseline Prostate Atrophy is Associated with Reduced Risk of Prostate Cancer in Men Undergoing Repeat Prostate BiopsyDaniel M Moreira, David G Bostwick, Gerald L Andriole, et al.
BJU International|September 24, 2013
The surgical spectacle: a survey of urologists viewing live case demonstrationsSammy E Elsamra, Mathew Fakhoury, Hector Motato, et al.
Pageof 15